Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akihisa Sutani is active.

Publication


Featured researches published by Akihisa Sutani.


Journal of Cancer Research and Therapeutics | 2012

Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient

Yukari Tsubata; Akinobu Hamada; Akihisa Sutani; Takeshi Isobe

We herein describe a case of drug-induced interstitial lung disease (ILD) following treatment with erlotinib. The plasma trough concentration of erlotinib at the time of the ILD diagnosis was extremely elevated compared with the plasma maximum concentration on day 1. We hypothesized that this phenomenon was associated with the pharmacodynamic interaction with a concomitant drug. The present case indicates that erlotinib-induced ILD was associated with a high plasma concentration of erlotinib. Oncologists should be aware of the possibility of ILD induced by erlotinib, especially for patients with co-morbidities.


Journal of Thoracic Oncology | 2014

Association of EPAS1 Gene rs4953354 Polymorphism with Susceptibility to Lung Adenocarcinoma in Female Japanese Non-Smokers

Shinichi Iwamoto; Keiji Tanimoto; Yumi Nishio; Andika Chandra Putra; Hiroshi Fuchita; Miki Ohe; Akihisa Sutani; Takashige Kuraki; Keiko Hiyama; Isao Murakami; Hidetaka Eguchi; Takeshi Isobe

Introduction: Hypoxia-inducible factor-2&agr; (also called endothelial periodic acid–Schiff domain protein 1 [EPAS1]) seems to play an important role in some carcinogenesis, though there is no information on the relationship between single nucleotide polymorphism of EPAS1 and lung cancer development. The aim of this study was to explore a possible association of the EPAS1 gene rs4953354 polymorphism with susceptibility to lung cancer. Methods: A case–control study of 346 patients with non–small-cell lung carcinoma (adenocarcinoma = 249, squamous cell carcinoma = 97) and 247 healthy control subjects was carried out. A/G polymorphism within an intron 2 of the EPAS1 (rs4953354) was determined by direct sequencing. Results: A frequency of lung adenocarcinoma patients with a minor allele G (A/G or G/G genotype) at the rs4953354 was much higher than that of controls (odds ratio, 1.800; 95% confidence interval, 1.161–2.791; p = 0.008). This association was more evident when analyzed using female never-smokers (odds ratio, 3.31; 95% confidence interval, 1.21–9.01; p = 0.017). Mutations in epidermal growth factor receptor tended to be frequent in patients with G allele at the rs4953354, compared with those with other genotypes. Conclusion: The EPAS1 rs4953354 may be a potentially susceptible marker for development of lung adenocarcinoma, especially in female never-smokers.


Journal of Asthma | 2015

Comparison of clinical management of young and elderly asthmatics by respiratory specialists and general practitioners

Mitsuhiro Tada; Takashige Kuraki; Yasuyuki Taooka; Hiroshi Fuchita; Fumi Karino; Kiyotaka Miura; Shunichi Hamaguchi; Miki Ohe; Akihisa Sutani; Takeshi Isobe

Abstract Background: Asthmatic death in the elderly is a serious problem worldwide. Differences in clinical skill between respiratory specialists (RS) and general practitioners (GP) are important in asthma control. The aim of this study was to compare asthma management between RS and GP. Methods: A cross-sectional survey was carried out in Shimane, Japan, in February 2009 using a questionnaire about patient background, treatment, asthma control test (ACT) and adherence to treatment. We secured the cooperation of 48 clinics (39 private clinics and 9 general hospitals). Asthmatics were divided into the elderly and young groups, and also into the RS and GP groups. Results: Clinical data of 779 patients were available for analysis. Elderly patients constituted 464 (RS group: 192, GP group: 272), while those of the young group were 315 (RS group: 207, GP group: 108). RS prescribed inhaled corticosteroids (ICSs) to their elderly and young patients more than GP. The total ACT score was higher in young RS group than in young GP group, but no such difference was noted in the elderly. Despite more asthma-related symptoms, the ACT showed that elderly GP asthmatics used fewer rescue inhalers than elderly RS. Self-assessment was higher in elderly GP than elderly RS asthmatics. Adherence to therapy was better in elderly patients than young patients. Conclusions: Elderly asthmatics treated by GPs underestimated the severity of their asthma and asthmatics seen by GPs were undertreated. The results stress the need to engage patients in educational activities, to adhere to guidelines, and to improve the coordination between GP and RS.


Geriatrics & Gerontology International | 2012

A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non-elderly non-small-cell lung cancer patients.

Yukari Tsubata; Takeshi Honda; Tamio Okimoto; Kiyotaka Miura; Fumi Karino; Shinichi Iwamoto; Taeko Suzuki; Shunichi Hamaguchi; Hibiki Kanda; Akihisa Sutani; Takashige Kuraki; Takeshi Isobe

Aim:  The number of elderly patients with non‐small‐cell lung cancer (NSCLC) is increasing in Japan. We retrospectively analyzed and compared the safety and efficacy of chemotherapy in elderly and non‐elderly NSCLC patients who received chemotherapy at Shimane University Hospital.


Clinical Respiratory Journal | 2016

Up-regulated integrinα4β1 on systemic lymphocytes and serum IL-17A in interstitial pneumonia

Yasuyuki Taooka; Miki Ohe; Mitsuhiro Tada; Akihisa Sutani; Takeshi Isobe

In interstitial pneumonia (IP), lymphocytes play an important role in lung injury and the involvement of integrinα4β1 on leukocytes has previously been reported in animal models. Although the integrinα4β1 expression level is known to be up‐regulated by inflammatory cytokines, the involvement of interleukin (IL)‐17A is unclear. The purpose of this study is to address the possible involvement of integrinα4β1 on circulating lymphocytes and its correlation with serum IL‐17A in interstitial lung diseases (ILDs).


Multidisciplinary Respiratory Medicine | 2014

Multiple logistic regression analysis of risk factors in elderly pneumonia patients: QTc interval prolongation as a prognostic factor

Yasuyuki Taooka; Gen Takezawa; Miki Ohe; Akihisa Sutani; Takeshi Isobe

BackgroundAcute pneumonia is a serious problem in the elderly and various risk factors have already been reported, but the involvement of QTc interval prolongation remains uncertain. The aim of this study was to elucidate the prognostic factors for the development of pneumonia in elderly patients and to study the possible involvement of QTc interval prolongation.MethodsThe subjects were 249 hospitalized pneumonia patients more than 65 years old in Aki-Ohta Hospital from January 2010 to December 2013. Community-acquired pneumonia patients and nursing care and healthcare-associated pneumonia patients were included in the study. The pneumonia severity index, vital signs, blood chemistry data and ECG findings were retrospectively compared using multiple logistic regression analysis.Results39 patients died within 30 days from onset. The clinical features related to poor prognosis were: advanced age, past history of cerebral vascular disease and/or diabetes mellitus, decreased serum albumin level, higher CURB-65 or PORT index scores and QTc interval prolongation. Patients showing a prolonged QTc interval had a higher mortality than those with a normal QTc interval. A prolonged QTc interval was not related to serum calcium concentration and/or treatment with QTc prolongation drug, clarithromycin or azithromycin, but related to age, lower albumin concentration and past history of diabetes mellitus.ConclusionsThese findings suggest potential prognostic factors for pneumonia in elderly patients, including a prolonged QTc interval (> 0.44 seconds).


Journal of Infection and Chemotherapy | 2013

Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia

Fumi Karino; Kiyotaka Miura; Hiroshi Fuchita; Naoya Koba; Emiko Nishikawa; Takamasa Hotta; Tamio Okimoto; Shinichi Iwamoto; Yukari Tsubata; Mitsuhiro Tada; Shunichi Hamaguchi; Takeshi Honda; Miki Ohe; Akihisa Sutani; Takashige Kuraki; Hiroyasu Takeyama; Takeshi Isobe


Biological & Pharmaceutical Bulletin | 2014

Nephrotoxicity Induced by Piperacillin–Tazobactam in Late Elderly Japanese Patients with Nursing and Healthcare Associated Pneumonia

Fumi Karino; Nobuhiro Nishimura; Noriyuki Ishihara; Hidehiko Moriyama; Kiyotaka Miura; Shunichi Hamaguchi; Akihisa Sutani; Takashige Kuraki; Kazuro Ikawa; Norifumi Morikawa; Kohji Naora; Takeshi Isobe


Anticancer Research | 2014

Immunohistochemical Comparison of Biomarker Expression in Biopsy and Surgical Specimens of Non-small Cell Lung Cancer

Tamio Okimoto; Yukari Tsubata; Akihisa Sutani; Hiroshi Fuchita; Naoya Koba; Takamasa Hotta; Megumi Hamaguchi; Kiyotaka Miura; Shunichi Hamaguchi; Miki Ohe; Takashige Kuraki; Yuji Harada; Riruke Maruyama; Nobuhiro Miyamoto; Koji Kishimoto; Takeshi Isobe


Anticancer Research | 2013

Phase I Clinical and Pharmacokinetic Study of Bi-weekly Carboplatin/Paclitaxel Chemotherapy in Elderly Patients with Advanced Non-small Cell Lung Cancer

Yukari Tsubata; Tamio Okimoto; Kiyotaka Miura; Fumi Karino; Shinichi Iwamoto; Mitsuhiro Tada; Takeshi Honda; Shunichi Hamaguchi; Miki Ohe; Akihisa Sutani; Takashige Kuraki; Akinobu Hamada; Takeshi Isobe

Collaboration


Dive into the Akihisa Sutani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge